CareDx Inc Statistics
Share Statistics
CareDx Inc has 53.63M shares outstanding. The number of shares has increased by -2.51% in one year.
| Shares Outstanding | 53.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.26% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 50.22M |
| Failed to Deliver (FTD) Shares | 185 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 3.45M, so 6.43% of the outstanding shares have been sold short.
| Short Interest | 3.45M |
| Short % of Shares Out | 6.43% |
| Short % of Float | 6.87% |
| Short Ratio (days to cover) | 3.71 |
Valuation Ratios
The PE ratio is -3.39 and the forward PE ratio is 40.21.
| PE Ratio | -3.39 |
| Forward PE | 40.21 |
| PS Ratio | 2.3 |
| Forward PS | 3.5 |
| PB Ratio | 2.47 |
| P/FCF Ratio | -23.35 |
| PEG Ratio | n/a |
Enterprise Valuation
CareDx Inc has an Enterprise Value (EV) of 597.20M.
| EV / Earnings | -3.14 |
| EV / Sales | 2.13 |
| EV / EBITDA | -6.66 |
| EV / EBIT | -2.94 |
| EV / FCF | -21.62 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.
| Current Ratio | 4.02 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.73% and return on capital (ROIC) is -68.86%.
| Return on Equity (ROE) | -0.73% |
| Return on Assets (ROA) | -0.41% |
| Return on Capital (ROIC) | -68.86% |
| Revenue Per Employee | 441.46K |
| Profits Per Employee | -299.66K |
| Employee Count | 635 |
| Asset Turnover | 0.6 |
| Inventory Turnover | 5.24 |
Taxes
| Income Tax | 141.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 130.09% in the last 52 weeks. The beta is 1.8, so CareDx Inc's price volatility has been higher than the market average.
| Beta | 1.8 |
| 52-Week Price Change | 130.09% |
| 50-Day Moving Average | 24.75 |
| 200-Day Moving Average | 19.39 |
| Relative Strength Index (RSI) | 45.2 |
| Average Volume (20 Days) | 826.66K |
Income Statement
In the last 12 months, CareDx Inc had revenue of $280.32M and earned -$190.28M in profits. Earnings per share was $-3.54.
| Revenue | 280.32M |
| Gross Profit | 178.32M |
| Operating Income | -203.36M |
| Net Income | -190.28M |
| EBITDA | -89.66M |
| EBIT | -203.36M |
| Earnings Per Share (EPS) | -3.54 |
Balance Sheet
The company has $82.20M in cash and $34.22M in debt, giving a net cash position of $47.98M.
| Cash & Cash Equivalents | 82.20M |
| Total Debt | 34.22M |
| Net Cash | 47.98M |
| Retained Earnings | -678.27M |
| Total Assets | 476.99M |
| Working Capital | 252.65M |
Cash Flow
In the last 12 months, operating cash flow was -$18.39M and capital expenditures -$9.24M, giving a free cash flow of -$27.63M.
| Operating Cash Flow | -18.39M |
| Capital Expenditures | -9.24M |
| Free Cash Flow | -27.63M |
| FCF Per Share | -0.51 |
Margins
Gross margin is 63.61%, with operating and profit margins of -72.55% and -67.88%.
| Gross Margin | 63.61% |
| Operating Margin | -72.55% |
| Pretax Margin | -67.83% |
| Profit Margin | -67.88% |
| EBITDA Margin | -31.98% |
| EBIT Margin | -72.55% |
| FCF Margin | -9.86% |
Dividends & Yields
CDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -15.43% |
| FCF Yield | -2.25% |
Analyst Forecast
The average price target for CDNA is $32, which is 39.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $32 |
| Price Target Difference | 39.5% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 2.53 |
| Piotroski F-Score | 5 |